Skip to Main content
Home > About > News > AmeriHealth Caritas Awarded Contract to Serve New Hampshire’s Medicaid Population

Press Releases

AmeriHealth Caritas New Hampshire Appoints Board Certified Addiction Psychiatrist Donald McNally, D.O., as Medical Director of Behavioral Health and Substance Use Disorders

AmeriHealth Caritas New Hampshire, a managed care organization serving New Hampshire Medicaid enrollees and part of the AmeriHealth Caritas Family of Companies, announced the appointment of Dr. Donald McNally as medical director of behavioral health and substance use disorders.

In this role Dr. McNally oversees the development of programs reflecting AmeriHealth Caritas New Hampshire's commitment to building a fully-integrated program that treats behavioral, physical, and dental health equally. He is also tasked with the implementation of current AmeriHealth Caritas Family of Companies' initiatives related to substance use at the health plan. Dr. McNally is responsible for elevating the treatment of behavioral health and substance use disorders to create parity with physical health. Additionally, Dr. McNally will lead the strategy and development of AmeriHealth Caritas New Hampshire's implementation plan for Emergency Room Psychiatric Boarding.

Dr. McNally comes to AmeriHealth Caritas New Hampshire after serving as an addiction psychiatrist for Maine Behavioral Healthcare and holding several leadership roles within the organization related to substance use care. Dr. McNally oversaw an outpatient treatment hub, a multidisciplinary team, and an intensive outpatient program.

Dr. McNally holds a Doctor of Osteopathic Medicine degree from the University of New England. He completed his residency in general psychiatry at the Institute of Living/Hartford Hospital where he was chief resident and received the Cornelis Boelhouwer Award for excellence in education and leadership. He also completed a fellowship in addiction psychiatry at Yale University.

According to the National Institute on Drug Abuse, New Hampshire has one of the five-highest rates of opioid-involved deaths among all states.1 McNally's hiring aligns with AmeriHealth Caritas Family of Companies' commitment to addressing the opioid crisis in New Hampshire and elsewhere, as well as its commitment to integrate  behavioral health and physical health.

In 2015, AmeriHealth Caritas Family of Companies launched its Opioid Blueprint (PDF) which helped curb opioid use and increased utilization of medication-assisted treatment in other states. The Opioid Blueprint focuses on pharmacy interventions, provider support, and member engagement.2 The Blueprint also reflects AmeriHealth Caritas Family of Companies' whole-person approach to care, integrating physical and behavioral health, while addressing social determinants of health.

"Few states have been hit harder by the opioid epidemic than New Hampshire. The state has made this a high priority for the Medicaid Care Management program, and we share that sense of urgency," said AmeriHealth Caritas New Hampshire Market President Scott Westover. "Dr. McNally's expertise will help us better serve our members dealing with substance use disorder."

"Medicaid health plans are often on the front lines of substance use disorder treatment. And AmeriHealth Caritas Family of Companies’ approach to this all-too-common health problem has produced very positive results," said McNally. "I have worked my entire career to create true parity between behavioral and physical health in order to advance the care of individuals. I look forward to helping the AmeriHealth Caritas New Hampshire team create and implement New Hampshire-specific solutions based on this proven approach."

1New Hampshire Opioid Summary. National Institute on Drug Abuse, March 2019. https://www.drugabuse.gov/opioid-summaries-by-state/new-hampshire-opioid-summary

2AmeriHealth Caritas Opioid Blueprint Demonstrates Benefits of Managed Care in Preventing and Combating Substance Use Disorders. AmeriHealth Caritas Press Release, 23 Oct 2018. https://www.amerihealthcaritas.com/news/2018/102318-opioid-blueprint.aspx